IP
RCPI

Isthmus Partners’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Isthmus Partners’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40
Closed – – 283
2015
Q3 		$0 Hold
40
– – ﹤0.01% 285
2015
Q2 		$0 Hold
40
– – ﹤0.01% 288
2015
Q1 		$0 Hold
40
– – ﹤0.01% 284
2014
Q4 		$0 Buy
+40
New +$210 ﹤0.01% 278

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Isthmus Partners's RCPI Position: Q4 2015 in Review

Isthmus Partners sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 40 shares.

Isthmus Partners first reported a position in RCPI in Q4 2014 and held it in 4 quarters. The position peaked at $0 in Q3 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Isthmus Partners reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Isthmus Partners sold 40 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
  • Isthmus Partners first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 4 quarters.
  • Isthmus Partners's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q3 2015.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Isthmus Partners's 13F filing for Q4 2015, filed 1 Feb 2016.